June 2010
Carnegie Learning Hosts National Math Institute for Educators
Carnegie Learning will host the Carnegie Learning National Math Institute, an intensive three-day professional development institute focused on raising middle school and high school student achievement in math. Attendance is limited but open to all Carnegie Learning teachers, leaders and administrators, as well as educators interested in learning more about a research-based, student-centered approach to middle school and secondary mathematics instruction. Registration can be completed in advance at http://nmi.carnegielearning.com or on-site if space is available. Visit www.carnegielearning.com to learn more.
Jun 29 | Permalink
Precision to Launch Genomics Product
Precision Therapeutics is planning to launch a "genomics" product in 2011. Exciting news from a company that filed a $34 million Series D fund-raise just last week. Other than saying that all of the company's products will be geared toward more effective treatment for cancer, CEO Sean McDonald offered few details. Learn more about Precision Therapeutics on www.precisiontherapeutics.com.
Jun 17 | Permalink
Carnegie Learning Named School Improvement Partner for WVa
The state of West Virginia has selected Carnegie Learning as a comprehensive school improvement partner to help the state turn around underperforming schools. Twenty-seven schools in West Virginia are eligible to apply for a share of the state's $22 million in School Improvement funds. Districts receiving School Improvement funds agree to make significant changes to the school structure and school day. Carnegie Learning is an approved School Improvement Grant partner in the state of Hawaii and is working as a School Improvement partner in districts in Washington and Indiana. Learn more at www.carnegielearning.com.
Jun 17 | Permalink
Precision Therapeutics Raises $34M
Precision Therapeutics has raised $33.97 million of a targeted $35 million in a mixed securities offering, according to an SEC filing. Since 1996, Precision has raised $63 million in venture funding. Read the filing at http://tinyurl.com/3xxu6m7.
Jun 7 | Permalink
BodyMedia Featured in Abstracts at ACSM Annual Meeting
Ten studies at the 57th Annual American College of Sports Medicine (ACSM) Meeting presented results suggesting the validity and benefits of BodyMedia's activity monitoring technology. BodyMedia's positive and measurable outcomes in these studies serve as a testament to the patented multisensory technologies for a variety of markets -- consumers, health and fitness clubs, corporate wellness programs and healthcare practitioners.
Jun 7 | Permalink
Study Suggests ChemoFx-Assisted Chemo Reduces Costs
A study published in the American Journal of Obstetrics and Gynecology (AJOG) demonstrated the cost savings realized through the use of the ChemoFx Drug Response Marker from Precision Therapeutics for assisting selection of treatment in recurrent ovarian cancer. The study demonstrated that ChemoFx-assisted chemotherapy may result in substantially reduced costs compared with empiric therapy. Learn more about ChemoFx at www.precisiontherapeutics.com.
Jun 4 | Permalink
